Antiemesis, version 2.2017: Featured updates to the NCCN Guidelines Journal Article

  


Authors: Berger, M. J.; Ettinger, D. S.; Aston, J.; Barbour, S.; Bergsbaken, J.; Bierman, P. J.; Brandt, D.; Dolan, D. E.; Ellis, G.; Kim, E. J.; Kirkegaard, S.; Kloth, D. D.; Lagman, R.; Lim, D.; Loprinzi, C.; Ma, C. X.; Maurer, V.; Michaud, L. B.; Nabell, L. M.; Noonan, K.; Roeland, E.; Rugo, H. S.; Schwartzberg, L. S.; Scullion, B.; Timoney, J.; Todaro, B.; Urba, S. G.; Shead, D. A.; Hughes, M.
Article Title: Antiemesis, version 2.2017: Featured updates to the NCCN Guidelines
Abstract: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 15
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2017-07-01
Start Page: 883
End Page: 893
Language: English
DOI: 10.6004/jnccn.2017.0117
PROVIDER: scopus
PUBMED: 28687576
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85022329776&doi=10.6004%2fjnccn.2017.0117&partnerID=40&md5=cfdeef9cbe277e828c1c7db143247da2
Notes: Review -- Export Date: 2 August 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. John Patrick Timoney
    10 Timoney
Related MSK Work